《臨床泌尿生殖癌》是世界上首屈一指的同行評(píng)審的，專門針對(duì)腫瘤的臨床腫瘤雜志，專門發(fā)表臨床相關(guān)的關(guān)于前列腺癌、尿癌和腎癌的檢測、診斷、預(yù)防和治療的文章。索引在index medicus/medline/pubmed、isi（當(dāng)前內(nèi)容/臨床醫(yī)學(xué)、科學(xué)引文索引擴(kuò)展（科學(xué)網(wǎng)）、期刊引文報(bào)告）、embase、cinahl和化學(xué)文摘中。每一期的臨床泌尿生殖系統(tǒng)癌癥都有同行評(píng)審的原始貢獻(xiàn)，邀請(qǐng)全面的評(píng)論，以及當(dāng)前的治療報(bào)告，以及每年主要腫瘤學(xué)會(huì)議的“會(huì)議要點(diǎn)”報(bào)告。同時(shí)也包括了最新新聞的簡要社論，以及為臨床醫(yī)生提供的有關(guān)泌尿生殖系統(tǒng)癌癥的最新話題?！杜R床泌尿生殖癌》是一本同行評(píng)議的雜志，發(fā)表了描述泌尿生殖癌臨床和轉(zhuǎn)化研究各個(gè)方面的原創(chuàng)文章。臨床泌尿生殖癌是專門的文章檢測、診斷、預(yù)防和治療泌尿生殖癌。重點(diǎn)是與泌尿生殖系統(tǒng)惡性腫瘤有關(guān)的所有領(lǐng)域的最新科學(xué)發(fā)展。具體的關(guān)注領(lǐng)域包括臨床研究和機(jī)械方法；藥物敏感性和耐藥性；基因和反義治療；病理學(xué)、標(biāo)志物和預(yù)后指標(biāo)；化學(xué)預(yù)防策略；多模式治療；以及各種方法的整合。

Clinical Genitourinary Cancer is the world’s premier peer-reviewed, tumor-specific, clinical oncology journal devoted to publishing clinically relevant articles on detection, diagnosis, prevention, and treatment of prostate, urinary, and renal cancers. Indexed in Index Medicus/Medline/Pubmed, ISI (Current Contents/Clinical Medicine, Science Citation Index Expanded (Web of Science), Journal Citation Reports), EMBASE, CINAHL, and Chemical Abstracts. Each issue of Clinical Genitourinary Cancer features peer-reviewed original contributions, invited comprehensive reviews, and current treatment reports, as well as "Meeting Highlights" reports taken from major oncology meetings each year. Also included are brief editorials of current news and the latest topics concerning genitourinary cancer for the clinician.Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.